INS and type 2 diabetes mellitus: So far, Ciglitazone was never used as a medication, while rosiglitazone and pioglitazone are authorized for the treatment of type II diabetes as monotherapy or in combination with insulin, metformin or sulfonylurea, but their prescription and use are under several restrictions because of their potential side effects.